Nursing Care Needs for Childhood Conditions
High-Yield Examination Topics for Childhood Urinary Conditions
1. Urinary Tract Infection (UTI)
Causative Agent: Escherichia coli (E. coli) from the gut is the most common cause of UTI in children.
Diagnostic Gold Standard:
Urine Culture: Significant bacteriuria is defined as >100,000 CFU/mL (clean-catch) or >50,000 CFU/mL (catheterized).
Invasive Procedures: Suprapubic Aspiration (SPA) is the most sterile method for non-toilet-trained children.
Clinical Signs by Age:
Infants: Often present with nonspecific symptoms like poor feeding, jaundice, or irritability.
Children: Present with localized signs like dysuria, urgency, and suprapubic pain.
Prevention (Critical for Education):
Wipe from front to back (especially in females).
Avoid tight clothing and use cotton underwear.
Ensure frequent voiding and complete bladder emptying.
2. Acute Glomerulonephritis (AGN)
Etiology: Most commonly follows a Group A hemolytic streptococcal infection (Post-streptococcal glomerulonephritis).
Classic Presentation Triad:
Hematuria: Often described as "tea-colored" or "smoky" urine with RBC casts.
Edema: Primarily periorbital (around the eyes).
Hypertension: Requires frequent monitoring (2-4 hourly) to prevent seizures.
Nursing Management: Maintain strict intake-output (I/O) records, daily weights, and sodium-restricted diets.
3. Nephrotic Syndrome
Defining Characteristics:
Massive Proteinuria (>3 to 3.5 g/day).
Hypoalbuminemia (low serum protein).
Generalized Edema and Hyperlipidemia.
Primary Treatment: Corticosteroids (e.g., Prednisone) are the first-line therapy to reduce glomerular permeability.
Fluid Assessment: Daily weight at the same time and on the same scale is the most accurate indicator of fluid status.
4. Nephroblastoma (Wilm’s Tumor)
Epidemiology: Most common renal cancer in children, typically aged 2-5 years.
Key Finding: A firm, non-tender abdominal mass or swelling.
Staging and Treatment:
Multimodal Approach: Involves surgical nephrectomy, chemotherapy, and sometimes radiation.
Staging: Ranges from Stage 1 (localized/fully removable) to Stage 5 (bilateral involvement).
Safety Note: During assessment, excessive palpation of the abdominal mass should be avoided to prevent tumor rupture or seeding (metabolization).